Oncology on Silicon Polder

Future Tech Ventures Invests in SPCTR’s Instant Tumour Analysis Tech

Wed, 04 Feb 2026 09:53:55 +0000

Amsterdam, Wednesday 4 February 2026 Future Tech Ventures has funded SPCTR to accelerate an AI device that creates real-time tissue fingerprints, enabling surgeons to assess tumour margins instantly and significantly reducing the need for repeat surgeries.

EMA Begins Review of Enhertu Combination for First-Line Breast Cancer Therapy

Mon, 19 Jan 2026 10:15:49 +0000

Amsterdam, Monday 19 January 2026 The EMA has initiated a review of Enhertu with pertuzumab for first-line HER2-positive breast cancer, potentially updating a standard of care that has remained unchanged for over a decade.